tiprankstipranks
Trending News
More News >
Castle Biosciences (CSTL)
NASDAQ:CSTL
US Market

Castle Biosciences (CSTL) Revenue

Compare
434 Followers

Castle Biosciences Revenue

Castle Biosciences had a revenue of 87.99M in the quarter ending Mar 31, 2025, with 1.94%. This bring the company's revenue in the last twelve months to 347.08M, Decreased 4.52%. In the fiscal year ending Dec 31, 2024, Castle Biosciences had annual revenue of 332.07M with 51.09% growth.
Revenue (ttm)
347.08M
Revenue Growth
38.43%
P/S Ratio
1.77
Revenue/Employee
$423,557
Employees
784
Market Cap
$587.55M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
332.07M112.28M+51.09%
Dec 31, 2023
219.79M82.75M+60.38%
Dec 31, 2022
137.04M42.95M+45.65%
Dec 31, 2021
94.08M31.44M+50.18%
Dec 31, 2020
62.65M10.78M+20.79%
Dec 31, 2019
51.87M29.08M+127.62%
Dec 31, 2018
22.79M9.03M+65.67%
Dec 31, 2017
13.75M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis